Equity News Results

  • GLOBAL MARKETS-Wall Street heads for subdued start as Netflix, oil drop

    * Asian stock markets: https://tmsnrt.rs/2zpUAr4. * Risk aversion returns with virus concerns. * Rising infections in India rattle energy markets. * Bond traders eagerly await 20-year Treasury auction. By Huw Jones.

  • FOREX-Dollar firm as COVID-19 resurgence hits reflation trades

    * Graphic: World FX rates https://tmsnrt.rs/2RBWI5E. The U.S. dollar rose on Wednesday from a seven-week low hit overnight, as broad weakness in stock markets triggered by a resurgence of COVID-19 cases in countries from India to Japan fuelled renewed appetite for the safe-haven appeal of the greenback.

  • FOREX-Dollar firms from 7-week lows as risk appetite fades

    * Graphic: World FX rates https://tmsnrt.rs/2RBWI5E. The U.S. dollar firmed on Wednesday, rising from a seven-week low hit overnight, as broad-based weakness in stock markets triggered by a resurgence of COVID-19 cases in countries from India to Japan fuelled renewed appetite for the greenback.

  • Japanese shares extend losses as investors brace for more lockdowns

    Japanese shares extended losses on Wednesday as investor fears of potential lockdowns in the country's biggest cities cast doubts over the prospects of an economic reopening. Nikkei share average tumbled 2.03% to close at 28,508.55, while the broader Topix fell 1.98% to 1,888.18 - both indexes dropped the most in about a month.

  • COLUMN-When geopolitics matters to markets: Mike Dolan

    Fractious geopolitics doesn't always move world markets - but the summer of 2021 may give us some glimpse about exactly where and how it does. With the new U.S. administration of President Joe Biden asserting its foreign policy priorities, this month has seen a rise in tensions with the United States' most powerful rivals - China, Russia and even Iran.

  • Japanese shares extend sharp fall on COVID-19 lockdown worries

    Japanese shares extended a steep fall on Wednesday as fears of possible coronavirus-related lockdowns in Japan's biggest cities cast doubts over the prospects of an economic reopening. Nikkei share average tumbled 2.23% to 28,451.64, while the broader Topix fell 2.24% to 1,881.11, after losing the most in about a month in the previous session.

  • Dollar firm as COVID-19 resurgence hits reflation trades

    The U.S. dollar rose on Wednesday from a seven-week low hit overnight, as broad weakness in stock markets triggered by a resurgence of COVID-19 cases in countries from India to Japan fuelled renewed appetite for the safe-haven appeal of the greenback. The safety bid also supported the Swiss franc and the Japanese yen as the outlook for the global economy soured.

  • Stocks Close Lower as Nasdaq Drops 0.9% -- Update

    U.S. stocks fell Tuesday, extending their losses as investors assessed blue-chip companies' profits and sales prospects. Investors are looking to companies' first-quarter results and their outlooks for the rest of the year to gauge whether valuations on stocks are justified. Strong U.S. economic data has bolstered expectations and fueled the recent rally that has left major indexes hovering close to records.

  • Stocks Close Lower As Nasdaq Drops 0.9%

    U.S. stocks slipped Tuesday, extending their losses as investors assess blue-chip companies' profits and sales prospects. The Dow Jones Industrial Average dropped 0.8%, or 257 points, while the S&P 500 fell 0.7% and the Nasdaq Composite lost 0.9%. All three indexes declined Monday, breaking a recent winning streak.

  • Stocks Drop After Big Rally

    U.S. stocks slipped Tuesday, on track to extend their losses as investors assess blue-chip companies' profits and sales prospects. The Dow Jones Industrial Average dropped 0.9%, while the S&P 500 fell 0.8% and the Nasdaq Composite lost 1.2%. All three indexes declined Monday, breaking a recent winning streak.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.